ng-nitroarginine methyl ester and Hematologic Malignancies

ng-nitroarginine methyl ester has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kiehl, MG; Kienast, J; Meyer, J; Ostermann, H	1

Trials

1 trial(s) available for ng-nitroarginine methyl ester and Hematologic Malignancies

Article	Year
Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive care medicine, 1997, Volume: 23, Issue:5 Topics: Adult; Analysis of Variance; Antineoplastic Agents; Blood Pressure; Enzyme Inhibitors; Female; Heart Ventricles; Hematologic Neoplasms; Hemodynamics; Humans; Leukopenia; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Prospective Studies; Shock, Septic; Stroke Volume; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents	1997

Article

Year

Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock.

Intensive care medicine, 1997, Volume: 23, Issue:5

Topics: Adult; Analysis of Variance; Antineoplastic Agents; Blood Pressure; Enzyme Inhibitors; Female; Heart Ventricles; Hematologic Neoplasms; Hemodynamics; Humans; Leukopenia; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Prospective Studies; Shock, Septic; Stroke Volume; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents

1997